Yoshihisa Kitamura Selected Research

Yoshihisa Kitamura Research Topics

Disease

28	Parkinson Disease (Parkinson's Disease) 10/2021 - 03/2002
24	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 04/2002
13	Neoplasms (Cancer) 04/2022 - 01/2010
10	Treatment-Resistant Depressive Disorder 08/2020 - 01/2002
7	Cognitive Dysfunction 01/2021 - 10/2015
7	Amyloid Plaque 01/2012 - 04/2002
6	Brain Ischemia (Cerebral Ischemia) 01/2017 - 08/2007
5	Neuroblastoma 01/2018 - 11/2002
4	Ischemia 11/2020 - 02/2003
4	Stroke (Strokes) 11/2020 - 07/2011
4	Breast Neoplasms (Breast Cancer) 03/2020 - 01/2015
3	Lung Neoplasms (Lung Cancer) 04/2022 - 01/2017
3	Hemorrhage 04/2022 - 01/2014
3	Inflammation (Inflammations) 01/2022 - 01/2019
3	Cerebral Hemorrhage 01/2022 - 09/2016
3	Neuroinflammatory Diseases 01/2022 - 11/2007
3	Dementia (Dementias) 10/2021 - 03/2016
3	Delirium 08/2021 - 01/2015
3	Hypothermia 01/2008 - 11/2003
2	Tauopathies 04/2022 - 06/2007
2	Necrosis 03/2021 - 01/2013
2	Respiratory Tract Infections (Respiratory Tract Infection) 07/2020 - 01/2019
2	Constipation 01/2020 - 01/2018
2	Diarrhea 01/2020 - 01/2015
2	Pain (Aches) 01/2019 - 08/2018
2	Osteonecrosis (Kienbock's Disease) 01/2018 - 01/2015
2	Substance-Related Disorders (Drug Abuse) 01/2017 - 01/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 01/2003
2	Hypertension (High Blood Pressure) 01/2015 - 11/2011
2	Insulin Resistance 11/2011 - 04/2010
2	Hyperinsulinism (Hyperinsulinemia) 11/2011 - 05/2008
2	Morphine Dependence 09/2011 - 03/2008
2	Opioid-Related Disorders (Opiate Addiction) 04/2011 - 03/2008
2	Infarction (Infarctions) 01/2009 - 03/2008
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2009 - 06/2008
2	Hyperglycemia 05/2008 - 12/2007
1	Febrile Neutropenia 04/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2022
1	Synucleinopathies 10/2021

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2003
11	Amyloid (Amyloid Fibrils)IBA 04/2022 - 03/2010
11	Neuroprotective AgentsIBA 11/2020 - 02/2003
9	Dopamine (Intropin)FDA LinkGeneric 03/2015 - 03/2002
8	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2016 - 01/2002
8	Amyloid beta-PeptidesIBA 03/2010 - 04/2002
7	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2022 - 12/2008
6	AntioxidantsIBA 01/2021 - 07/2011
6	Pharmaceutical PreparationsIBA 03/2020 - 11/2003
6	Peptides (Polypeptides)IBA 01/2018 - 04/2002
5	Antidepressive Agents (Antidepressants)IBA 01/2017 - 06/2002
5	RotenoneIBA 01/2011 - 11/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 10/2015
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 07/2020 - 01/2019
4	Imipramine (Janimine)FDA LinkGeneric 11/2013 - 11/2003
3	Molecular Chaperones (Chaperone, Molecular)IBA 01/2017 - 03/2008
3	UCP0054278IBA 01/2017 - 03/2009
3	Pramipexole (Mirapex)FDA LinkGeneric 01/2014 - 07/2009
3	HMGB1 Protein (HMG1)IBA 01/2012 - 02/2003
2	LipidsIBA 04/2022 - 01/2015
2	Arachidonic Acid (Vitamin F)IBA 01/2022 - 08/2020
2	Thrombin FDA Link 01/2022 - 08/2020
2	CytokinesIBA 08/2020 - 06/2008
2	human ERBB2 proteinIBA 03/2020 - 01/2017
2	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2017
2	Magnesium Oxide (Magnesia)FDA Link 01/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2008
2	GABA-A Receptors (GABA(A) Receptor)IBA 01/2019 - 01/2015
2	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 11/2018 - 12/2007
2	3-(2,4-dimethoxybenzylidene)anabaseineIBA 01/2018 - 03/2013
2	Denosumab FDA Link 01/2018 - 01/2015
2	Zoledronic Acid (Zometa)FDA Link 01/2018 - 01/2015
2	Nicotine FDA Link 04/2017 - 04/2011
2	Nerve Growth Factor (NGF)IBA 01/2017 - 01/2010
2	Protein Deglycase DJ-1IBA 01/2017 - 01/2009
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2015 - 04/2007
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 03/2015 - 06/2003
2	O(4)-methylthymidine monophosphateIBA 01/2015 - 01/2013
2	Bupropion (Wellbutrin)FDA LinkGeneric 01/2014 - 08/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2012 - 03/2008
2	Levodopa (L Dopa)FDA LinkGeneric 01/2012 - 03/2002
2	FructoseIBA 11/2011 - 04/2010
2	Adrenergic Agents (Adrenergic Drugs)IBA 05/2010 - 05/2008
2	Insulin (Novolin)FDA Link 04/2010 - 05/2008
2	triphenyltetrazoliumIBA 01/2009 - 03/2008
2	Carbamazepine (Tegretol)FDA LinkGeneric 05/2008 - 04/2008
2	Serotonin (5 Hydroxytryptamine)IBA 12/2007 - 06/2002
1	Choline (Choline Chloride)IBA 04/2022
1	CefozopranIBA 04/2022
1	Cefepime (Maxipime)FDA LinkGeneric 04/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2022
1	lipoxin A4IBA 01/2022
1	kaempferolIBA 10/2021
1	SynucleinsIBA 10/2021

Therapy/Procedure

8	Therapeutics 11/2019 - 03/2002
7	Drug Therapy (Chemotherapy) 04/2022 - 10/2015
3	Transplantation 01/2020 - 10/2006
3	Aftercare (After-Treatment) 08/2018 - 12/2009
2	Terminal Care (Care, Terminal) 12/2019 - 01/2017
2	Kampo Medicine (Kampo) 01/2018 - 03/2010